Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis C
Open Access
- 4 July 2005
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 5 (8), 1909-1913
- https://doi.org/10.1111/j.1600-6143.2005.00976.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis CLiver Transplantation, 2004
- Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-upTransplantation, 2004
- Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized studyGastroenterology, 2003
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantationHepatology, 1997
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996
- Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis CJournal of Gastroenterology and Hepatology, 1996